Clinical trials: Bronchopleural Fistula
Bronchopleural Fistula
ENgineered Tissue Repair of BronchopleUral FiSTula
Phase I/II Open-label Study to Assess the Safety and Efficacy of a Novel Tissue Engineered Airway Product, Consisting of Expanded Autologous Bone Marrow (BM) Derived Mesenchymal Stromal Cells (MSC) Seeded on to a Decellularised…
- Trial name
- ENTRUST (NCT04435249)
- Testing
- BPF-001
- Sponsor
- Videregen Limited